Attention deficit hyperactivity disorder (ADHD) is a common, highly heritable psychiatric disorder characterized by hyperactivity, inattention and increased impulsivity. In recent years, a large number of genetic studies for ADHD have been published and related genetic data has been accumulated dramatically. To provide researchers a comprehensive ADHD genetic resource, we previously developed the first genetic database for ADHD (ADHDgene). The abundant genetic data provides novel candidates for further study. Meanwhile, it also brings new challenge for selecting promising candidate genes for replication and verification research. In this study, we surveyed the computational tools for candidate gene prioritization and selected five tools, which integrate multiple data sources for gene prioritization, to prioritize ADHD candidate genes in ADHDgene. The prioritization analysis resulted in 16 prioritized candidate genes, which are mainly involved in several major neurotransmitter systems or in nervous system development pathways. Among these genes, nervous system development related genes, especially SNAP25, STX1A and the gene-gene interactions related with each of them deserve further investigations. Our results may provide new insight for further verification study and facilitate the exploration of pathogenesis mechanism of ADHD.
INTRODUCTION
Attention deficit hyperactivity disorder (ADHD) is a common psychiatric disorder among children and adolescents with a prevalence of about 3%-7% (Faraone and Doyle, 2001) . The core clinical features of ADHD are lack of concentration, motor hyperactivity and severe impulsiveness, and it is often accompanied with other psychiatric disorders (Biederman et al., 1991) , which affect the education and social relationship of children. Twin and adoption studies of ADHD suggest that genetic influences contribute substantially to its etiology, with heritability estimates ranging from 75% to 91% (Faraone et al., 2005) . Thus, unraveling the genetic basis of ADHD is of fundamental importance in uncovering disease mechanism and potentially leads to novel diagnostic procedures and pharmacological treatment. Up to now, large numbers of association studies (Gizer et al., 2009) , linkage studies and meta-analyses (Neale et al., 2010) have been conducted to study the genetic mechanism of ADHD. To address the genetic complexity of ADHD and the heterogeneity of studies, we previously established the first genetic database for ADHD, named ADHDgene, to provide researchers a comprehensive and well-organized collection of genetic data of ADHD (Zhang et al., 2012) . Finally, ADHDgene provided 3589 ADHD candidate genes, in which, 213 genes were literature-origin and 3376 were from extended functional analysis, including linkage disequilibrium (LD) analysis, pathway-based analysis (PBA) of ADHD genome-wide association study (GWAS) data (Zhang et al., , 2011a and gene mapping.
The abundant genetic data provides plentiful novel can-didates for ADHD genetic study, but inconsistence and low replication rate exist for many genetic factors. Further candidate gene association studies are needed in larger samples for replication. However, geneticists are always confused with how to choose promising genes for replication from enormous amounts of candidate genes. Meanwhile, among these genetic factors, which are the causal variants and how these causal variants contribute to the pathogenesis of disease are still incompletely understood. Experimental research for molecular function of specific genes would be helpful to understand the etiology and pathophysiology of ADHD. However, it is infeasible for molecular biologists to validate each candidate. They would need to choose more reasonable genes before experiments. For this purpose, selection of the most promising candidates from large numbers of genetic factors will greatly reduce the time and cost. Therefore, the bioinformatics community has introduced the concept of gene prioritization to take advantage of both the progress made in computational biology and the large amount of genomic data publicly available. A basic assumption used by most of the strategies for gene prioritization is the "guilt-by-association" principle , which means the genes that are closer to disease genes in a network or other kinds of genomic data will be more likely to be associated with the same disease. Based on this principle, the inputs of these tools normally include two types of data. One is the prior knowledge about the genetic disorder of interest, which can be either a set of genes known to play a role in the disease or a set of keywords that describe the disease. The other is the candidate search space. The output normally is either a ranking list of the candidate genes or a selection of the most promising candidates. To evaluate how the candidate genes are "close" to the training genes, a set of characteristics that are most likely to fit the underlying disease genes (training genes) need to be defined from enormous amounts of information and then are used to score candidates. So, both high coverage and high quality data sources are important to make accurate predictions. A single data type might not be powerful enough to predict the disease-causing genes accurately while the use of several complementary data sources allow much more accurate predictions . Until now, most of the approaches make use of a wide range of data sources covering distinct views of the genes, including functional annotations (e.g. Gene Ontology (GO) (Ashburner et al., 2000) ), expression (e.g. Atlas gene expression from Ensembl (Flicek et al., 2011) ), regulatory information (e.g. TOUCAN (Aerts et al., 2005) ), text (co-citation and functional mining), protein-protein interaction networks (e.g. HPRD (Keshava Prasad et al., 2009) ), pathways (e.g. KEGG (Kanehisa et al., 2010) ), sequence similarity (BLAST (Altschul et al., 1990) ), phenotype (e.g. OMIM (McKusick, 2007) ), protein domain conservation (e.g. InterPro (Mulder and Apweiler, 2008) ) and chemical components. Besides high coverage and high quality data sources, another important issue for gene prioritization is the computational method to define the similarity between training genes and candidate genes. For different data sources, the similarity measures might be different (Kohler et al., 2008; Chen et al., 2009b) and finally, the scores from different data sources need to be integrated into one measure (Aerts et al., 2006; Chen et al., 2011a) . Because every tool uses separate benchmark, it is difficult to compare the performance of different tools. By now, there have been several application studies of gene prioritization tools in diseases (e.g. on type 2 diabetes (Tiffin et al., 2006; Elbers et al., 2007; Teber et al., 2009) ). Several gene prioritization tools were used in parallel in these studies to strengthen the results based on the hypothesis that genes selected by the most independent methods are at least likely to be false positives of the approach used (Elbers et al., 2007) .
In this study, in order to pick out promising candidate genes for further verification study from the large numbers of candidates provided in ADHDgene, we combined five web interface available tools, which all integrate multiple data sources and use different methods for similarity calculation, to prioritize ADHD candidate genes in ADHDgene. Our results may provide new insight for further replication study and facilitate the exploration of pathogenesis mechanism of ADHD.
RESULTS

Prioritized genes
After integrating the prioritization results from five tools, 16 candidate genes were detected as promising ADHD genes by at least 3 out of 5 methods (a summary of these candidate genes is shown in Table 1 ). There are 4 of the 16 genes supported by four tools and 12 of the 16 genes supported by three tools. Based on the hypothesis about the genetic influences of major neurotransmitter systems on ADHD (Sharp et al., 2009 ), 12 of the 16 genes are involved in dopaminergic, serotonergic, noradrenergic or nicotinic neurotransmitter systems. Among these genes, SLC6A4, DBH, HTR1B and HTR2A have been examined in many studies, but there are some genes (e.g. HTR3A, ADRB2 and CHRNA7) which have not been examined much by now and may be promising candidate for further study.
Besides the genes involved in the major neurotransmitter systems, the most interesting predictive results are the genes about nervous system development pathways, including SYT1, STX1A, VAMP2 and SNAP23. Although these genes were not investigated too much in previous studies, there is even no genetic study on SNAP23 which is mapped by PBA pathways in ADHDgene, they were still pinpointed by prioritization tools and SYT1 was even selected by four tools together. Fig. 1 illustrates the training gene sub-network produced by ToppNet (Chen et al., 2009b) which was created by using training genes and their immediate interactants. The network shows STX1A is strongly connected with four training genes (SNAP25, SLC6A2, SLC6A3 and SYP), and SNAP25 interacts with several important genes, including SYT1, VAMP2 and STX1A in our final results. SNAP25 codes for a protein involved in axonal growth and synaptic plasticity, as well as in the docking and fusion of synaptic vesicles in presynaptic neurons necessary for the regulation of neurotransmitter release (Sollner et al., 1993) . STX1A encodes a member of the superfamily of syntaxins, which are nervous system-specific proteins implicated in the docking of synaptic vesicles with the presynaptic plasma membrane. Syntaxin and SNAP25, together with vesicle-associated membrane protein termed synaptobrevin/VAMP form a complex which serves as a binding site for pre-and post-synaptic exocytosis (Kennedy and Ehlers, 2011) . Synaptobrevin/VAMP and syntaxin are believed to be involved in vesicular transport in most cells, while SNAP25 is present almost exclusively in the brain (Liu et al., 2011) . These results showed these nervous system development related genes and gene-gene interactions among them form an important network, which might contribute to the development of ADHD in a combination pattern and deserve more attention in the future studies.
Result evaluation
To evaluate the influence of the training genes on the final ranking result, we used another training data set (see detailed gene list in MATERIALS AND METHODS part) to execute the same gene prioritization procedure as our primary training data set. The comparison of these two ranking results showed 6 genes of the 16 candidate genes from our primary analysis were replicated in the second ranking results including DRD2, DRD3, SYT1, ADRB2, STX1A and TH, 4 genes of the 16 candidate genes are the training genes in the second ranking procedure including DBH, HTR1B, HTR2A and SLC6A4. Meanwhile, the most interesting results STX1A and SYT1 were both pinpointed by four tools in the second ranking results. The choice of data sources for gene prioritization tools might affect the final ranking result. In our primary analysis, we used all data sources provided by tools. We have also tried to remove several computational data sources to compare the results. When we removed data sources like 'GO', 'BLAST' and 'Interaction-String' in Endeavour and features 'GO' and 'computational' in ToppGene, we got 15 prioritized genes. Comparison with the original 16 prioritized genes showed that only gene HTR3A, CHRNA7, SNAP23 and ADRB2 were missed and HTR5A, HTR1A and TGFB1I1were gained, which shows the computational data sources will only bring minor changes on the results and will not affect the most interesting results such as STX1A and SYT1.
The 16 prioritized genes together with 13 training genes (29 genes in total) could be regarded as reliable ADHD candidate genes. Recently, Kang et al. (2011) published a spatio-temporal transcriptome of the human brain. We used their dataset to check the expression profiling of the 29 ADHD genes. The result shows five genes are region-enriched differentially expressed (Fig. 2) , in which DRD2, DRD3 and HTR1B are enriched in striatum, but DRD2 and DRD3 are differentially expressed in earlier development periods than HTR1B; CHRNA4 and TPH2 are enriched in mediodorsal nucleus of the thalamus from late fetal to late adulthood or adolescence. It has been reported that methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder (Volkow et al., 2012) . Smaller regional volume on the lateral thalamic surface was found in ADHD patient with hyperactivity and larger regional volumes on the medial thalamic surface was found in ADHD patient with inattention. These suggest the involvement of thalamic subcircuits is different in the pathogenesis of different ADHD symptoms (Ivanov et al., 2010) and regulation of gene expression in these regions may contribute to ADHD.
DISCUSSION Prioritized genes in major neurotransmitter systems
The main drug for ADHD treatment methylphenidate acts by (Kang et al., 2011) . © Higher Education Press and Springer-Verlag Berlin Heidelberg 2012 blocking the dopamine transporter, which together with the association of ADHD with those executive neuropsychological functions and frontostriatal dopaminergic pathways make the dopaminergic system become the most intensively analyzed neurotransmitter system in ADHD (Swanson et al., 2007) . DRD2, DRD3 and DBH in the 16 candidate genes as well as DRD4 and SLC6A3 in the training genes are all dopaminergic system related genes. Their associations with ADHD have been investigated in many studies (Gizer et al., 2009) , especially, DRD4 and SLC5A3 are the top two genes with the most studies in ADHDgene (Zhang et al., 2012) . The selections of DRD2 and DRD3 by prioritization tools are mainly because of their similar function with DRD4 although the studies about them are less and the results from different studies are inconsistent. Dopamine beta hydroxylase (DBH) converts dopamine to norepinephrine, and also represents an interesting candidate gene for ADHD. A meta-analysis (Gizer et al., 2009) shows that TaqI polymorphism in DBH shows a trend association with ADHD. The meta-analysis results also indicate there is significant heterogeneity of effect sizes across studies for DRD2 and DBH; further studies are needed to determine their effect during the development of ADHD.
Serotonin dysregulation has been related to impulsive behavior in children, and thus genes involved in serotonergic system have been hypothesized to play a causal role in ADHD (Oades, 2008) . Solute carrier family 6 (neurotransmitter transporter, serotonin) member 4 (SLC6A4) is the most tested serotonergic system related gene in ADHDgene (Zhang et al., 2012) . Several 5-hydroxytryptamine (serotonin) receptors (HTR1E, HTR1B, HTR2A and HTR3A) were also good candidates associated with ADHD. HTR3A has only one negative result by now in ADHDgene (Ribases et al., 2009 ), but it is selected by these tools because of its function similarity with other serotonin receptors. Tryptophan hydroxylase is the rate-limiting enzyme in the production of serotonin. Because recent studies showed TPH2 is responsible for tryptophan hydroxylase expression in the brain (Walther et al., 2003) , the association studies of ADHD have focused on TPH2 rather than TPH1 (Gizer et al., 2009; Sharp et al., 2009) . The monoamine oxidase genes encode enzymes involved in the metabolism of dopamine, serotonin, and norepinephrine. Two monoamine oxidase genes, MAOA and MAOB, are interesting candidates for association with ADHD. By now, more studies were conducted for MAOA than MAOB because of some specific supports for MAOA (Gizer et al., 2009 ), but the prioritization tools also detected MAOB from the training gene MAOA.
Adrenergic neurotransmitters are hypothesized to influence attentional processes and certain aspects of executive control (Arnsten, 2006) . The most frequently investigated genes of the noradrenergic system are those encoding the noradrenaline transporter (SLC6A2) and the adrenergic receptors (including ADRA2A, ADRA2C, ADRA1A, ADRA2B, ADRB1 and ADRB2). In our predicted results, ADRB2 was selected while SLC6A2 as training gene. The association between ADRB2 and ADHD was first tested in a sample of 776 DSM-IV ADHD combined type cases (Brookes et al., 2006) , which is the main source of our training genes. One interesting thing is that this gene is excluded from our training genes because the number of its significant result is less than two, but finally it is selected by prediction tools into our candidate genes. So, further attention on this gene may have some unexpected result.
Another interesting neurotransmitter system with suggested association with ADHD is the nicotinic neurotransmitter system. One of the evidences is that nicotine administration has been shown to improve attention and working memory deficits in adults diagnosed with ADHD (Levin, 2002) . The nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4) received the most attention thus far and it is also in our training data set. Another member of nicotinic acetylcholine receptors superfamily CHRNA7, homolog of CHRNA4, is in our prioritized results. Although it was only examined in one study and the result was non-significant, it may be also an interesting candidate because of its similarity with CHRNA4.
Prioritized genes in nervous system development pathways
The most studied nervous system development related gene is SNAP25 (synaptosomal-associated protein, 25 kDa). It has been suggested as a genetic susceptibility factor in ADHD in several studies (Gizer et al., 2009) . STX1A (syntaxin 1A (brain)) has been suggested to be a genetic susceptibility factor for autism (Nakamura et al., 2011) . However, until now, the genetic studies about SYT1, STX1A, VAMP2 and SNAP23 in ADHD are still scarce. SYT1 got evidences from four prioritization tools to be promising candidate for ADHD, but was only studied in three researches with one significant result in Chinese Han population (Guan et al., 2009) . STX1A also only got one significant result in a United Kingdom population (Brookes et al., 2005) , while, there is no significant result for VAMP2 thus far. SNAP23, a homolog of SNAP25, is structurally and functionally similar to SNAP25 and binds tightly to multiple syntaxins and synaptobrevins/VAMPs (Frank et al., 2011) . It is also selected by three tools as one of our final candidate genes although by now there is no genetic study about it in ADHD. To sum up, nervous system development pathway related genes, especially STX1A, SYT1, SNAP25 and their related interactions, deserve more investigation to help the exploration of the pathogenesis mechanism of ADHD.
CONCLUSION
The first genetic database of ADHD we developed at previous study (Zhang et al., 2012) provides abundant and novel candidates for ADHD genetic study, and meanwhile, brings new challenge for the selection of promising candidates for verification study. In this study, we used five gene prioritization tools based on multiple data sources and different methods for similarity calculation to prioritize all candidate genes in ADHDgene. Relatively credible genes from IMAGE team with one extra criterion were chosen as training genes and genes predicted by at least three tools were selected as promising candidate genes. Our analysis results provide 16 promising candidate genes for future replication and verification studies. Besides the genes involved in major neurotransmitter systems, the genes related with nervous systems development pathways may deserve more investigation in future studies, especially the gene-gene interactions related with STX1A and SNAP25. The results may provide new insights for the pathogenesis mechanism research of ADHD.
MATERIALS AND METHODS
Training data and test data
For the gene prioritization tools based on "guilt-by-association" principle, the training data set is important to get credible result. By now, there are no widely accepted ADHD-related genes as the core genes used in (Sun et al., 2009 ) for schizophrenia. The International Multicenter ADHD Genetics project (IMAGE) is an international collaborative study that aims to identify genes that increase the risk for ADHD using QTL linkage and association strategies. IMAGE investigators had selected 51 pre-specified ADHD autosomal candidate genes and used this gene set for candidate association study in a sample of 776 DSM-IV ADHD combined type cases ascertained for IMAGE (Brookes et al., 2006) . Finally, they found nominal significance with one or more SNPs in 18 genes. These genes were also analyzed in one ADHD GWAS study (Lasky-Su et al., 2008) and a meta-analysis of GWASs of ADHD (Neale et al., 2010) to examine the distribution of the association P-values of the SNPs in these genes. Among these 18 genes, 13 are replicated in at least two studies as significant results according to ADHDgene. Thus, we choose the 13 genes as training data set, they are as the following: CHRNA4, DDC, DRD4, FADS2, HTR1E, MAOA, PNMT, SLC6A2, SLC6A3, SLC9A9, SNAP25, SYP and TPH2. To evaluate the influence of the training data on the final ranking result, another training data set was used for result comparison, which includes genes in ADHDgene with at least ten study results and five significant results: DRD4, SLC6A3, SLC6A4, COMT, DRD5, SNAP25, MAOA, DBH, BDNF, SLC6A2, HTR1B, HTR2A and TPH2 . The test data set included 3576 genes in ADHDgene except those genes in training data set.
Selection of gene prioritization tools
Because our training data and test data are both candidate gene lists, the tools using keywords or expression dataset as training data and the tools using region or genome as candidate genes were excluded. According to the inputs/outputs statistics in "Gene Prioritization Portal" website , only seven tools satisfy the above criterion: DIR (Chen et al., 2011a) , Endeavour (Aerts et al., 2006; Tranchevent et al., 2008) , GeneWanderer (Kohler et al., 2008) , Prioritizer , TargetMine (Chen et al., 2011b) , ToppGene and ToppNet (Chen et al., 2009b ). When we further checked the websites of these tools, we found GeneWanderer only accepts genomic region as candidates, not gene list; Prioritizer has been moved from a living web application to a program to download and the candidates for the local version software can also only be genomic regions. In addition, the data sets in GeneWanderer and Prioritizer have not been updated for relatively long time. So finally, we chose the other five tools to prioritize ADHD candidate genes.
Basic information about these gene prioritization tools is summarized in Table 2 . All of these tools are based on multiple data sources, but the data sources and the computational methods for similarity measure might be different among tools. DIR (Chen et al., 2011a) uses an expandable framework for gene prioritization that can integrate multiple heterogeneous data sources by taking advantage of a unified graphic representation. Endeavour (Aerts et al., 2006 ) is the first gene prioritization tool using multiple data sources. It was maintained and updated continually (Tranchevent et al., 2008) and has been used in several applications (Aerts et al., 2009; Thienpont et al., 2010) . TargetMine (Chen et al., 2011b ) is a powerful database for gene enrichment analysis, and the "unsupervised" protocol for prioritization is one of its applications, in which, input candidate genes are enriched to several biological terms (e.g. KEGG pathways, GO terms) and prioritized genes are collected from the significantly enriched biological terms. ToppGene and ToppNet are in one suite of tools for gene functional enrichment and prioritization (Chen et al., 2009b) . ToppGene is for candidate gene prioritization based on functional similarity to training gene list (Chen et al., 2007) . ToppNet is for ranking candidate genes based on topological features in protein-protein interaction network (Chen et al., 2009a) . Both ToppGene and ToppNet were used in our analyses and are listed separately in Table 2 as two different tools. The inputs of DIR, Endeavour, ToppGene and ToppNet are the same, including a list of training genes and a list of candidate genes. The input of TargetMine is only a list of candidate genes, no training data is required. Except the input gene lists, default parameters and all data sources for these tools were used. The outputs of DIR, Endeavour, ToppGene and ToppNet are all ranked candidate genes with scores. Whereas the outputs of ToppNet also include a graphical network and Cytoscape-compatible input file to demonstrate the training gene sub-network. The outputs of TargetMine are candidate gene enriched biological terms, including but not limited to KEGG pathways, GO terms and OMIN phenotypes. Prioritized genes were collected from the top biological terms.
Identification of candidate genes
Because TargetMine pinpoints candidate gene enriched biological terms, the top seven biological terms for KEGG pathways, GO terms and disease ontology terms respectively were collected (according to the original paper, the threshold of top seven terms was by and large most suited to ensuring maximum coverage and minimum overprediction (Chen et al., 2011b) ). The intersections among genes from these three types of biological terms were regarded as the results from TargetMine. For the results from DIR, Endeavour, ToppGene and ToppNet which all produce rankings, the top 30 genes from each method were included for comparison. A gene was considered to be A fuzzy-based similarity measure was used to compute the similarity between any two genes based on semantic annotations. Similarity scores from different data sources are combined into an overall score using statistical metaanalysis.
ToppNet (Chen et al., 2009b) http://toppgene.cchmc.org/ Protein-protein interaction network (BIND, Bio-GRID, HPRD)
Prioritize or rank candidate genes based on topological features in protein-protein interaction network using PageRank with Priors, HITS with Priors and K-step Markov algorithms.
interesting as a candidate gene if it was indicated by at least three or more of these tools.
